Copyright: ©Author(s) 2026.
World J Gastroenterol. Dec 7, 2026; 32(45): 121126
Published online Dec 7, 2026. doi: 10.3748/wjg.121126
Published online Dec 7, 2026. doi: 10.3748/wjg.121126
Figure 2 Kaplan-Meier survival curves for the peptide receptor radionuclide therapy group and control group.
A: Progression-free survival; B: Overall survival. PRRT: Peptide receptor radionuclide therapy.
- Citation: Zheng QM, Chen CY, Zhang L, Sun JS, Wang HH, Xie Y, Guo QJ, Jiang WT. Peptide receptor radionuclide therapy for recurrent neuroendocrine tumors after liver transplantation. World J Gastroenterol 2026; 32(45): 121126
- URL: https://www.wjgnet.com/1007-9327/full/v32/i45/121126.htm
- DOI: https://dx.doi.org/10.3748/wjg.121126